Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Email
Post
Print
Shireen Khan, PhD (she/her/hers)
VP of Biology and Pharmacology
Totus Medicines, Inc.
Poster(s):
(581) Targeting IRF5 with selective covalent oral small molecules attenuates Type I IFN and pro-inflammatory cytokine secretion in human PBMCs and in mice
Thursday, April 16, 2026
11:30 AM - 12:30 PM
US ET
Email Shireen
